Famotidine (oral)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Famotidine (oral) is a gastric acid secretion inhibitor that is FDA approved for the treatment of heartburn. Common adverse reactions include constipation ,diarrhea, dizziness , headache.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- Duodenal ulcer
- Esophagitis - Gastroesophageal reflux disease,
- Gastric hypersecretion
- Gastric ulcer,
- Gastroesophageal reflux disease
- Indigestion
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Famotidine (oral) in adult patients.
Non–Guideline-Supported Use
Indications
- Esophagitis, Maintenance
- Gastritis
- Gastrointestinal hemorrhage
- Stress ulcer
- Urticaria
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Indication
- Duodenal ulcer
- Esophagitis - Gastroesophageal reflux disease,
- Gastric hypersecretion
- Gastric ulcer,
- Gastroesophageal reflux disease
- Indigestion
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Famotidine in pediatric patients.
Non–Guideline-Supported Use
Indications
- Stress ulcer; Prophylaxis
Contraindications
There is limited information regarding Famotidine (oral) Contraindications in the drug label.
Warnings
There is limited information regarding Famotidine (oral) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Famotidine (oral) Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Famotidine (oral) in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Famotidine (oral) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Famotidine (oral) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Famotidine (oral) with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Famotidine (oral) with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Famotidine (oral) with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Famotidine (oral) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Famotidine (oral) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Famotidine (oral) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Famotidine (oral) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Famotidine (oral) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Famotidine (oral) in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Famotidine (oral) in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Famotidine (oral) in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Famotidine (oral) in the drug label.
Pharmacology
There is limited information regarding Famotidine (oral) Pharmacology in the drug label.
Mechanism of Action
Structure
File:Famotidine (oral)01.png This image is provided by the National Library of Medicine.
01.png){kind=link}
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Famotidine (oral) in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Famotidine (oral) in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Famotidine (oral) in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Famotidine (oral) in the drug label.
How Supplied
Storage
There is limited information regarding Famotidine (oral) Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Famotidine (oral) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Famotidine (oral) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Famotidine (oral) in the drug label.
Precautions with Alcohol
- Alcohol-Famotidine (oral) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
7 SELECT ACID CONTROLLER
Look-Alike Drug Names
- A® — B®[1]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ "http://www.ismp.org". External link in
|title=(help)
{{#subobject:
|Page Name=Famotidine (oral)
|Pill Name=No image.jpg
|Drug Name=
|Pill Ingred=|+sep=;
|Pill Imprint=
|Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
|Pill Color=|+sep=;
|Pill Shape=
|Pill Size (mm)=
|Pill Scoring=
|Pill Image=
|Drug Author=
|NDC=
}}
{{#subobject:
|Label Page=Famotidine (oral) |Label Name=Famotidine (oral)11.png
}}
{{#subobject:
|Label Page=Famotidine (oral) |Label Name=Famotidine (oral)11.png
}}